Search

everythinglearnresearchcommunity

for

Search:↓

Both genetic and lifestyle factors significantly affect female hair loss.

The document concludes that female pattern baldness involves hair thinning, is classified differently than in men, and is assessed using the Ludwig classification. It also explains the hair growth cycle stages.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.

Trichoscopy helps diagnose and manage different types of hair loss in the Indian population.

Low-dose oral minoxidil may help treat hair loss but is not FDA-approved and can cause side effects like unwanted hair growth and heart issues.

A young man with an unusual type of scarring hair loss suggests a possible new variant of a known scalp condition.

The document describes how to tell different types of non-scarring hair loss apart by looking at hair and scalp tissue under a microscope.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Finasteride improves hair growth and satisfaction in men with male pattern baldness but may cause sexual side effects.

Scalp biopsies are essential for accurately diagnosing alopecia areata.

Testosterone can cause acne and male-pattern baldness, affects hair growth in men and women, and makes male skin more sensitive.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Minoxidil and finasteride are the only FDA-approved treatments for hair loss caused by genetic and hormonal factors, but their effectiveness is often doubted, indicating a need for new treatments.

Different genes cause Female Pattern Hair Loss compared to male hair loss, and treatments vary, but more research is needed to understand it fully.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Many women experience significant hair loss during menopause, and topical minoxidil is an effective treatment.

The document concludes that treatments like oral anti-androgens, minoxidil, and topical spironolactone can be effective for hair loss in men and women.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Male hair loss is mainly due to thinner hair, not less hair.

PRP treatment improves hair growth, and the device used can affect results, with some being more effective.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

The study found that two enzymes linked to hair loss are located in different parts of the scalp, supporting a common treatment's effectiveness.

Hair diversity is influenced by complex genetics and environmental factors, requiring more research for practical solutions.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Normal hair density and diameter ratios were established to help diagnose adult hair loss.

Trichoscopy is useful for quickly diagnosing different types of hair loss without needing biopsies.